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Celiac artery thrombosis in a young patient with
multiple platelet receptor polymorphisms and local
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Jens Rudolph, MD,a Siamak Pourhassan, MD,a Fuat Saner, MD,b Rainer B. Zotz, MD,c and
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Numerous clinical and experimental studies have been published concerning platelet receptor polymorphism and their
role in causing myocardial infarction at an earlier age. It is still unclear, however, whether these polymorphisms are a risk
factor for other occlusive diseases such as those in visceral arteries. We report a case of a young woman with acute celiac
artery thrombosis and multiple platelet receptor polymorphisms. In addition, the intraoperative exploration showed
some evidence of a local vascular compression syndrome. The patient was successfully treated with a bypass procedure and
combined anticoagulation. It seems that platelet receptor polymorphisms are a moderate risk factor for local artery
thrombosis regardless of vascular region. The obligatory precondition is pre-existing vascular damage, such as that caused
by a local compression syndrome. (J Vasc Surg 2008;48:1335-7.)Since the first description of platelet receptor polymor-
phisms in the mid-1990s, numerous clinical and experi-
mental studies have been published concerning their
role.1-5 These studies have confirmed that coronary infarc-
tions are more common and occur at an earlier age.
To date there is still a lack of information on a possible
causal relation between platelet receptor polymorphism
and occlusion of other arterial beds except those of the
coronary system. Our report describes a case of celiac artery
occlusion in a young patient with multiple platelet receptor
polymorphisms.
CASE REPORT
A 20-year-old woman suffered from discomfort and pain in
the upper abdomen for several months. Her complaints were not
related to food intake and no weight loss could be detected. Prior
to admission, the severity and the frequency of the symptoms
increased.
At onset of diarrhea, the patient presented at a local hospital.
After 3 days of unsuccessful conservative medical treatment on an
outpatient basis, she was admitted. On admittance, the septic
patient presented with an acute abdomen. Under the working
diagnosis “appendicitis,” a laparoscopic appendectomy was per-
formed. The appendix appeared macroscopically and histologically
normal. Abdominal inspection showed a “moderate swelling of the
small bowel.”
Upon further deterioration of her condition during the fol-
lowing 3 days with fever, elevation of leucocytes and C-reactive
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doi:10.1016/j.jvs.2008.05.038protein, and signs of peritonitis (Table), the patient underwent
computed tomography (CT) scanning. The images revealed a
complete infarction of the spleen and occlusion of the celiac artery
due to a thrombus extending into the aorta (Fig 1). Cholecystitis
and ischemia of the right colic flexure were suspected.
The emergency operation confirmed gangrene of the gallblad-
der, irreversible ischemia of the terminal ileum, and complete
infarction of the spleen. The abdomen was opened by median
laparotomy, and the celiac artery was exposed by dissecting the
smaller omentum. After a C-shaped incision of the aorta was made
at the ostium of the celiac artery, the thrombectomy was per-
formed by balloon.
The red thrombus was several days old and clearly adherent to
the vessel wall, which showed no evidence of atherosclerotic alter-
ations. However, the celiac artery was critically compressed by the
arcuate ligaments, which is typical for celiac artery compression
syndrome (CACS). Dividing these ligaments resulted in a com-
plete freeing of the celiac artery, so no further revascularization
procedure seemed necessary. The superior mesenteric artery was
open and perfused.
After revascularization, cholecystectomy and resection of the
ischemic terminal ileum were performed.
A CT scan performed the following day showed reocclusion of
the celiac trunk (Fig 2). An immediate relaparotomy confirmed
reduced hepatic perfusion. Revascularization was possible by only
an aortohepatic bypass to the right hepatic artery using the saphe-
nous vein. For intraoperative bypass control, Doppler sonography
was used.
Postoperative CT angiography showed a patent reconstruc-
tion but reduced perfusion of the left hepatic lobe (Fig 3). Because
of threatening liver failure, the patient was transferred to a center
for liver and transplantation surgery.
The further course of vascular reconstruction was uneventful.
The thrombophilia workup excluded factor V Leiden mutation;
prothrombin mutation; protein C, protein S, and antithrombin defi-
ciency; and methylenetetrahydrofolate reductase polymorphism.
Other clinical causes, such as pregnancy, malignancy, dehydration,
and oral contraceptives, were not present. However, two platelet
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latory disorder were found (GP IIIa-polymorphismHPA 1b-allele,
GP Ia-IIa-polymorphism GP Ia C807T). Furthermore, we sus-
pected heparin-induced thrombocytopenia type 2 because of a
positive heparin-induced platelet activation test despite normal
thrombocyte count, negative antibodies, and lack of white clots
intraoperatively. Anticoagulation was continued with hirudin and
aspirin perioperatively; the patient was discharged on warfarin
medication. The CT follow-up 12 months later showed a patent
bypass.
DISCUSSION
Acute occlusion of visceral arteries are rare in young
patients. Themost common cause is fibromuscular displasia
or vessel dissection in congenital diseases of the connective
tissue (Marfan and Ehlers-Danlos syndrome). The role of
platelet hyperreactivity due to genetically determined poly-
Table. Laboratory findings
Result Normal range
Leucocytes 40.5/nL 10.0/nL
Platelets 507/nL 150-350/nL
Hemoglobin 11.9 g/% 12.3-15.3 g/%
Potassium 3.2 mmol/L 3.6-5.0 mmol/L
Lactate dehydrogenase 358 U/L 248 U/L
Serum glutamic-
oxaloacetic
transaminase
(SGOT) 43 U/L 35 U/L
Serum glutamic-pyruvic
transaminase (SGPT) 41 U/L 34 U/L
Cholinesterase 3.0 U/L 4.7-10.4 U/L
Alpha-amylase 250 U/L 30-110 U/L
C-reactive protein 33.0 mg/% 1.0 mg/%
Fibrinogen 1189 mg/% 200-450 mg/%
D-dimer 1.010 g/mL 0.24 g/mL
Findings were normal for sodium, alkaline phosphatase, creatinine kinase,
lipase, creatinin, urea, bilirubin, cholesterol, triglycerides, glucose, thrombin
time, and antithrombin.
Fig 1. Computed tomography scan on admission shows throm-
bosis of celiac trunk.morphism in platelet receptors is still not fully understood.Thrombocyte receptors are polymorphic glycopro-
teins, most of which are intergrins that carry diallele
alloantigens. These alloantigens are human platelet anti-
gens (HPAs). Among the most important integrins are
IIb3 (HUGO gene nomenclature ITGA2B ITGB3),
also known as glycoprotein IIb-IIIa, and 21 (HUGO gene
nomenclature ITGA2 ITGB1), known as glycoprotein Ia-
IIa.6
The IIb-IIIa-receptor binds to fibrinogen, von Wil-
lebrand factor, fibronectin, vitronectin, and throm-
bospondin. The receptor mediates thrombocyte aggre-
gation. The 3 subunit carries HPA-1.
6 A higher risk of
myocardial ischemia has been documented for carriers of
theHPA-1b allele,2 andmore recent reports have discussed
the importance of these findings.3
The Ia-IIa-receptor mediates binding to collagen. Its
2 subunit is polymorphic in section C807T. The 2–
807TT genotype is associated with enhanced receptor
expression on the thrombocyte membrane. In vitro this
condition leads to increased binding to collagen. The clin-
ical relevance of this polymorphism, for example with re-
spect to myocardial ischemia, is also a matter of discussion.4
In a recent study involving over 3000 patients, Zotz
et al5 were able to show that individuals carrying the
HPA-1b allele or those with the 2-807TT genotype are at
risk of myocardial infarction 5.2 or 6.3 years earlier than
those without. However, these findings applied to only
patients with histories of coronary disease.
The potential risk factor of platelet receptor polymor-
phisms in visceral ischemias and other vascular beds except
the coronary system has not yet been studied.
We present a case of a young patient showing sub-
acute thrombotic occlusion of the celiac artery with
CACS and multiple platelet receptor polymorphisms
(HPA-1b of the GP IIb-IIIa receptor and 2-807TT of
the GP Ia-IIa receptor). Thrombectomy and decompres-
sion of the celiac artery alone led to rethrombosis. Suc-
cessful revascularization was achieved only by bypassing
the altered celiac artery and adminstering high-dosage
anticoagulants.
Thrombotic occlusion of the celiac artery is not com-
mon in CACS. In our opinion, the combination of multiple
receptor polymorphisms and damage to the vascular wall
due to CACS played the pivotal role in this case.
We think the small-bowel ischemia was caused by em-
bolism attributable to thrombotic material at the orifice of
the celiac artery/aorta.
Platelet receptor polymorphism alone without precon-
ditioning morphologic damage of the vascular wall does
not seem to be associated with a higher rate of thrombem-
bolic events in the arterial system. Therefore, a specific
treatment is not necessary; anticoagulation therapy espe-
cially seems inappropriate.
In contrast, vascular damages, mostly atherosclerotic
lesions, demand a continuing antithrombotic treatment.
The role of coumadines remains unclear.
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Thrombocyte receptor polymorphism may very likely
be a moderate risk factor for arterial thromboses when
damage to the vascular wall is present. Platelet receptor
polymorphism should be excluded in young patients with
Fig 2. Computed tomography scan on first po
Fig 3. Computed tomography scan after successful revasculariza-
tion by vein graft to right hepatic artery.unclear thrombembolic events in the arterial system.The authors thank K. Rascher and C. Nill for their
support.
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